Ultralife Corporation (NASDAQ: ULBI) reported operating income of
$0.4 million on revenue of $37.0 million for the quarter ended June 27,
2010. For the second quarter of 2009, the company reported an operating
loss of $6.3 million on revenue of $39.6 million.
... read more
XSell today unveiled its new brand initiative and visual identity. The re-branding
affirms XSell’s transformation from a cross-selling focused application
to a sophisticated multi-channel interaction management platform. XSell
will communicate this perspective in the new corporate name, Swyft
Technology, which also serves as the cornerstone of ... read more
WARREN, NJ -- (Marketwire) -- 07/29/10 -- ANADIGICS, Inc. (NASDAQ: ANAD), a leading
provider of semiconductor solutions in the broadband wireless and wireline
communications markets, reported second quarter 2010 net sales of $51.7
million, a sequential increase of 18.7% and an increase of 64.2% above the
second quarter of 2009. For the six months ended July 3, 2010, net sales
were $95.2 million, up approximately 54% over the prior year. As of July
3, 2010, cash, cash equivalents and short and long-term ... read more
SAN DIEGO, CA -- (Marketwire) -- 07/29/10 -- eAccess LLC, a Cubic Corporation (NYSE: CUB) subsidiary that supplies smart card products, RFID solutions and services, will deliver 1 million smart cards to the Port Authority of New York and New Jersey (PATH) under a new three-year-contract.
eAccess will deliver a substantial quantity of Limited Use Contactless Smart Cards later this summer. The cards will be packaged with a secure RFID shield for convenient storage and retail handling, and will ... read more
PLEASANTON, CA -- (Marketwire) -- 07/29/10 -- APCO Booth #939 -- As leading providers of integrated public safety solutions, Positron Front Line and its parent company Tiburon, Inc. announce a strategic partnership agreement with Intrado Inc., the leading provider of 9-1-1 technology solutions. Positron Front Line has also become Intrado's preferred computer aided dispatch (CAD) solutions provider and will continue to deliver integrated solutions with Intrado's call-handling applications.
As part of the agreement, Positron Front Line has committed to ... read more
AECOM Technology Corporation (NYSE: ACM), a leading provider of
professional technical and management support services for government
and commercial clients around the world, announced today that Resources
Sciences Arabia Limited, a joint venture in which it participates with
Xenel, has been awarded a program management contract ... read more
Correlix Ltd., the leading
provider of Latency Intelligence(TM) solutions for monitoring, measuring and
analyzing order and market-data flows in real-time, today announced that
Direct Edge, America's newest stock exchange, has selected Correlix's
RaceTeam latency monitoring service to provide full latency transparency of
order execution and market data flow in real-time to its customers.
The RaceTeam service will enable Direct Edge to provide real-time latency
insight into its new EDGX and EDGA exchanges, including displaying the
matching engine timing. This new level of data availability ... read more
Science Applications International Corporation (SAIC) (NYSE: SAI) today announced it has been awarded a task order by the Naval Surface Warfare Center (NSWC) - Crane Division to provide technical, training and armory management support to the military services and other law enforcement agencies. The task order has a two-year base period of performance, three one-year award term periods, and a total value of more than $35 million, if all award term periods are exercised. Work will be performed at NSWC ... read more
Exar Corporation (Nasdaq: EXAR) will hold its fiscal 2011 first quarter financial results conference call on July 29, 2010 at 1:30 p.m. PDT. Exar will release its fiscal 2011 first quarter financial results following the market close on July 29, 2010. To access the conference call, please dial (800) 230-1085 after 1:20 p.m. PDT. In addition, a live webcast will be available on Exar's Investors' Homepage at: http://www.exar.com/news/investornews.aspx. A taped replay of the conference call will be available starting ... read more
Diebold, Incorporated (NYSE: DBD) today reported second quarter 2010 income from continuing operations attributable to Diebold, net of tax, of $30.4 million, or $.46 per share, down 5% and 4% respectively from the second quarter 2009. Second quarter 2010 revenue was $665.2 million, down 4% from second quarter 2009.
(Logo: http://photos.prnewswire.com/prnh/20080725/DIEBOLDLOGO )
(Logo: http://www.newscom.com/cgi-bin/prnh/20080725/DIEBOLDLOGO )
Non-GAAP earnings per share* from continuing operations attributable to Diebold, net of tax, in the second quarter 2010 were $.52, up 2% from second quarter 2009.
"We ... read more
Abaxis, Inc. (Nasdaq: ABAX), a medical products company manufacturing point-of-care blood analysis systems, has scheduled a conference call to discuss its financial results for the first quarter of fiscal year 2011, ended June 30, 2010. The call will be at 4:15 p.m. ET on Thursday, July 29, 2010.
Participants can dial (877) 317-6789 or (412) 317-6789 to access the conference call, or can listen via a live Internet web cast, which is available in the Investor Relations section of the company's ... read more
In conjunction with its second quarter 2010 earnings release (expected to be issued after market close on July 28, 2010), Covance Inc. (NYSE: CVD) is pleased to invite you to listen to its quarterly investor conference call that will be broadcast live over the Internet on Thursday, July 29, 2010 at 9:00 a.m. ET.
Covance Second Quarter 2010 Earnings Webcast and Slide
... read more
CHARLOTTE, N.C., July 29, 2010 /PRNewswire-FirstCall/ --
-- Full year 2010 outlook for net income per diluted share increased to
$4.30 - $4.45. Sales outlook remains unchanged at approximately $7.1
billion. Net cash provided by operating activities, minus capital
expenditures, remains unchanged, and is expected to exceed 85 percent of
... read more
Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS), a biopharmaceutical company dedicated to improving patient care by developing novel medicines for the treatment of hepatitis C, today reported its financial results and program highlights for the second quarter ended June 30, 2010.
"In the second quarter we continued to advance the development of ANA598, and we enhanced the Company's financial position through a $12.5M equity offering," said Steve Worland, Ph.D., President and CEO of Anadys. "We believe the SVR12 data reported today, combined ... read more
Star Plaza, inclusive of the Radisson Hotel at Star Plaza and the renowned Star Plaza Theatre, officially announced today the unveiling of a new website - www.StarPlaza.com - a virtual showcase of one of Chicagoland's longstanding top destinations.
(Photo: http://photos.prnewswire.com/prnh/20100729/DE42376-a )
(Photo: http://www.newscom.com/cgi-bin/prnh/20100729/DE42376-a )
(Logo: http://photos.prnewswire.com/prnh/20100729/DE42376LOGO-b )
(Logo: http://www.newscom.com/cgi-bin/prnh/20100729/DE42376LOGO-b )
The website reveals and encapsulates Star Plaza's "new look," a nod to both the property's 40-year legacy and its dedication to ever-evolving style. The website also boasts an illustrative view into ... read more
Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) today announced that six of six patients (100%) in the ANA598 200 mg twice daily (bid) arm who were randomized to stop all treatment at Week 24 in an ongoing Phase II trial maintained undetectable levels of virus 12 weeks after stopping treatment, referred to as Sustained Virological Response 12, or SVR12.
The Company also reported that all available patients from the ANA598 200 mg arm who were previously reported to have undetectable levels of ... read more
announced today that Jon Curnow has joined the team as director of
product. Jon will spearhead the company’s product development efforts to
ensure its advertising intelligence solutions continue to meet the needs
of publishers around the globe. Jon has more than 13 years of experience ... read more
Inc. (Nasdaq: IMGN) announced
today that the company will present at two investor conferences in the
next two weeks. These presentations will be webcast live and can be
accessed through the “Investor Information” section of the Company’s
website, www.immunogen.com. ... read more
AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO), a biopharmaceutical company
focused on discovering, developing and commercializing cancer
therapeutics, today provided an update on recent research and
development (R&D) and business accomplishments, and announced financial
results for the quarter ended June 30, 2010.
... read more